India’s robotic surgery procedures surged from 8,912 in 2021 to 44,857 by 2025, with Delhi-NCR emerging as the primary hub. While this shift signals a maturing healthcare market, investors should monitor high operational costs, training requirements, and insurance coverage as key factors for long-term sustainability.
Robotic-assisted surgery is rapidly gaining traction in Indian healthcare. Data presented at the Society of Robotic Surgery (SRS) India 2026 conference shows a significant rise in annual procedure volumes, which jumped from 8,912 in 2021 to 44,857 by 2025. This fivefold increase reflects a broader technological shift in how hospitals deliver specialized care, moving from niche adoption to regular clinical practice across fields like urology, gynecology, and general surgery.
Delhi-NCR currently stands as the country’s leading hub for this technology. As of the latest update, 39 hospitals in the region have installed robotic systems, with 11 facilities operating multiple units. Procedure volumes in this hub alone climbed from 2,257 in 2021 to 10,937 in 2025, positioning the region as a primary center for training and clinical throughput. This concentration of infrastructure creates a testing ground for surgical technology that is currently difficult to replicate in other parts of the country.
The sector is eyeing substantial growth, with market projections estimating a value of nearly $4 billion by fiscal year 2031 and a steady annual growth rate of roughly 10% through 2036. This transition is opening new avenues for large hospital chains and technology suppliers involved in the robotic ecosystem. However, the path to widespread profitability faces distinct challenges.
Despite the growth, the industry faces significant financial and operational hurdles. High acquisition and maintenance costs for robotic systems remain a barrier for many institutions. Furthermore, insurance coverage often categorizes these procedures as elective rather than a medical necessity, which can limit patient accessibility and create revenue unpredictability for hospitals. Long-term financial sustainability depends on maintaining high procedure volumes, with industry standards often requiring at least 120 surgeries per year per system, alongside a continuous need for specialized surgeon training.
The recent focus on telesurgery—demonstrated by remote procedures performed across significant distances—points toward future possibilities for accessing remote specialist care in Tier-2 and Tier-3 cities. However, the successful expansion into these regions will depend on reliable digital infrastructure, robust cybersecurity frameworks, and evolving regulatory guidelines. Investors tracking this sector may monitor whether health insurance policies adapt to cover these procedures and if hospitals can maintain the required utilization rates to make these capital-intensive investments profitable over the coming years.